Technology Networks – Investigational Drug Could Provide At-Home Treatment-Resistant Depression Care

CMO Hans Eriksson discusses the challenges of developing new treatments for treatment-resistant depression and the potential of dual-acting NMDA receptor modulation to address current gaps in care.